why choose us

First received: June 26, 2023

Clinical Trial: Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Urticaria

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy, and Safety Study of Povorcitinib in Participants With Chronic Spontaneous Urticaria

Brief Summary: This study is being conducted to evaluate the efficacy and safety of povorcitinib in adults with CSU that is inadequately controlled using SOC treatments.

Read more